Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: Randomized placebo-controlled trial

AIM: To estimate if and to what extent long acting octreotide (LAR) improves survival and quality of life in patients with advanced hepatocellular carcinoma (HCC). METHODS: A total of 127 cirrhotics, stages A-B, due to chronic viral infections and with advanced HCC, were enrolled in the study. Scint...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Dimitroulopoulos, D, Xinopoulos, D, Tsamakidis, K, Zisimopoulos, A, Andriotis, E, Panagiotakos, D, Fotopoulou, A, Chrysohoou, C, Bazinis, A, Daskalopoulou, D, Paraskevas, E
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2007
Assuntos:
Liver Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4436600/
https://ncbi.nlm.nih.gov/pubmed/17589893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i23.3164
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados